GNbAC1

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	24

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 10 of 24 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001973-21-SE (EUCTR)	09/07/2021	04/06/2021	Extension of Study GNC-401 with temelimab in patients with Multiple Sclerosis under treatment with r ...	A long-term extension of Study GNC-401 with temelimab in patients with Relapsing forms of Multiple S ...	Multiple Sclerosis MedDRA version: 21.0;Level: PT;Classification code 10080700;Term: Relapsing multi ...	Product Name: Temelimab Product Code: GNbAC1 INN or Proposed INN: TEMELIMAB Product Name: Temelimab Prod ...	GeNeuro Innovation SAS	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 2	Sweden
2	EUCTR2019-004822-15-SE (EUCTR)	18/05/2020	17/01/2020	A Clinical Trial Examining the Effects of Temelimab Following Rituximab Treatment in Patients with M ...	A Randomized, Double-Blind, Placebo Controlled Trial, Examining the Safety, Tolerability, Pharmacody ...	Multiple Sclerosis MedDRA version: 21.0;Level: PT;Classification code 10080700;Term: Relapsing multi ...	Product Name: Temelimab Product Code: GNbAC1 INN or Proposed INN: temelimab Product Name: Temelimab Prod ...	GeNeuro Innovation SAS	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 2	Sweden
3	NCT03574428 (ClinicalTrials.gov)	May 8, 2018	16/5/2018	Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers	A Randomised, Double-Blind, Placebo Controlled, Single Ascending Doses Study With GNbAC1in Healthy M ...	Multiple Sclerosis	Drug: GNbAC1;Other: GNbAC1 Placebo	GeNeuro Australia PTY Ltd	NULL	Completed	18 Years	55 Years	Male	24	Phase 1	Australia
4	EUCTR2016-004935-18-IT (EUCTR)	20/11/2017	22/01/2021	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 21.1;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1	GENEURO SA	NULL	Not Recruiting			Female: yes Male: yes	200	Phase 2	Serbia;Czechia;Estonia;Spain;Ukraine;Russian Federation;Italy;Hungary;Czech Republic;Poland;Croatia; ...
5	EUCTR2016-004935-18-HR (EUCTR)	26/06/2017	12/09/2017	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 20.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1 INN or Proposed INN: Not Available	GeNeuro SA	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Serbia;Hungary;Estonia;Czech Republic;Poland;Spain;Ukraine;Croatia;Russian Federation;Bulgaria;Germa ...
6	EUCTR2016-004935-18-PL (EUCTR)	26/06/2017	07/04/2017	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 20.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1 INN or Proposed INN: Not Available	GeNeuro SA	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Serbia;Hungary;Estonia;Czech Republic;Spain;Poland;Ukraine;Croatia;Russian Federation;Bulgaria;Germa ...
7	EUCTR2016-004935-18-BG (EUCTR)	22/06/2017	11/04/2017	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 20.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1 INN or Proposed INN: Not Available	GeNeuro SA	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Estonia;Czech Republic;Poland;Spain;Ukraine;Serbia;Hungary;Croatia;Russian Federation;Bulgaria;Germa ...
8	EUCTR2016-004935-18-DE (EUCTR)	19/06/2017	16/02/2017	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 20.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1 INN or Proposed INN: Not Available	GeNeuro SA	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Serbia;Hungary;Estonia;Czech Republic;Poland;Spain;Ukraine;Croatia;Russian Federation;Bulgaria;Germa ...
9	NCT03239860 (ClinicalTrials.gov)	June 6, 2017	12/7/2017	Assessing the HERV-W Env ANtagonist GNbAC1for Evaluation in an Open Label Long-term Safety Study in ...	A Long-Term International, Extension of Study GNC-003 With GNbAC1in Patients With Relapsing Remittin ...	Multiple Sclerosis, Relapsing-Remitting	Drug: GNbAC1 Monoclonal Antibody	GeNeuro SA	Les Laboratoires Servier;Worldwide Clinical Trials;Institut de Recherches Internationales Servier	Terminated	18 Years	55 Years	All	220	Phase 2	Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukrain ...
10	EUCTR2016-004935-18-CZ (EUCTR)	01/06/2017	20/02/2017	A clinical study to assess the long-term safety of GNbAC1 in patients with Multiple Sclerosis	A Long-Term International, Extension of Study GNC-003, with GNbAC1in Patients with Relapsing Remitti ...	Multiple Sclerosis (MS) MedDRA version: 20.0;Level: PT;Classification code 10063399;Term: Relapsing- ...	Product Name: GNbAC1 Product Code: GNbAC1 INN or Proposed INN: Not Available	GeNeuro SA	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Serbia;Hungary;Estonia;Czech Republic;Poland;Spain;Ukraine;Croatia;Russian Federation;Bulgaria;Germa ...

First Previous1 2 3Next Last